Denali Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-16,409
| Closed | -$501K | – | 326 |
|
|
2025
Q2 | $501K | Hold |
16,409
| – | – | 0.05% | 225 |
|
|
2025
Q1 | $443K | Buy |
+16,409
| New | +$520K | 0.05% | 243 |
|
|
2024
Q4 | – | Sell |
-34,000
| Closed | -$1.29M | – | 313 |
|
|
2024
Q3 | $1.29M | Buy |
34,000
+12,700
| +60% | +$522K | 0.14% | 155 |
|
|
2024
Q2 | $964K | Sell |
21,300
-3,400
| -14% | -$156K | 0.26% | 88 |
|
|
2024
Q1 | $1.2M | Sell |
24,700
-22,400
| -48% | -$1.1M | 0.35% | 71 |
|
|
2023
Q4 | $2.52M | Sell |
47,100
-29
| -0.1% | -$1.47K | 0.77% | 45 |
|
|
2023
Q3 | $2.76M | Buy |
47,129
+6,800
| +17% | +$425K | 0.97% | 36 |
|
|
2023
Q2 | $2.54M | Sell |
40,329
-10,400
| -21% | -$662K | 0.89% | 35 |
|
|
2023
Q1 | $3.19M | Sell |
50,729
-2,500
| -5% | -$149K | 1.33% | 31 |
|
|
2022
Q4 | $2.83M | Buy |
53,229
+15,716
| +42% | +$851K | 1.19% | 37 |
|
|
2022
Q3 | $2.1M | Buy |
37,513
+17,500
| +87% | +$1.16M | 0.99% | 39 |
|
|
2022
Q2 | $1.45M | Sell |
20,013
-1,000
| -5% | -$74.5K | 0.63% | 53 |
|
|
2022
Q1 | $1.67M | Hold |
21,013
| – | – | 0.64% | 52 |
|
|
2021
Q4 | $2.13M | Hold |
21,013
| – | – | 0.8% | 49 |
|
|
2021
Q3 | $1.94M | Sell |
21,013
-2,500
| -11% | -$241K | 0.81% | 46 |
|
|
2021
Q2 | $2.41M | Buy |
23,513
+11,000
| +88% | +$1.1M | 0.92% | 45 |
|
|
2021
Q1 | $1.22M | Buy |
12,513
+12,303
| +5,859% | +$1.12M | 0.38% | 95 |
|
|
2020
Q4 | $16K | Buy |
210
+10
| +5% | +$774 | ﹤0.01% | 321 |
|
|
2020
Q3 | $15K | Buy |
+200
| New | +$16K | ﹤0.01% | 339 |
|
|
2018
Q2 | – | Sell |
-55
| Closed | -$5K | – | 310 |
|
|
2018
Q1 | $5K | Hold |
55
| – | – | ﹤0.01% | 152 |
|
|
2017
Q4 | $4K | Buy |
+55
| New | +$3.68K | ﹤0.01% | 186 |
|
|
2017
Q3 | – | Sell |
-50
| Closed | -$3K | – | 298 |
|
|
2017
Q2 | $3K | Buy |
+50
| New | +$3.08K | ﹤0.01% | 203 |
|
|
2016
Q4 | – | Sell |
-31,710
| Closed | -$2.19M | – | 312 |
|
|
2016
Q3 | $2.19M | Buy |
+31,710
| New | +$2.09M | 0.33% | 69 |
|
|
2014
Q2 | – | Sell |
-42
| Closed | -$2K | – | 293 |
|
|
2014
Q1 | $2K | Sell |
42
-26
| -38% | -$908 | ﹤0.01% | 222 |
|
|
2013
Q4 | $3K | Hold |
68
| – | – | ﹤0.01% | 186 |
|
|
2013
Q3 | $3K | Hold |
68
| – | – | ﹤0.01% | 133 |
|
|
2013
Q2 | $2K | Buy |
+68
| New | +$2.07K | ﹤0.01% | 154 |
|
Other funds holding USNA
SWGC
Denali Advisors's USNA Position: Q3 2025 in Review
Denali Advisors sold out of Usana Health Sciences (USNA) in Q3 2025, closing a stake of 16,409 shares — an estimated $501K sold.
Denali Advisors first reported a position in USNA in Q2 2013 and held it in 27 quarters. The position peaked at $3.19M in Q1 2023. 165 funds tracked by Wall St. Rank hold USNA as of Q3 2025.
- Denali Advisors reported no remaining Usana Health Sciences position as of Q3 2025 after selling out during the quarter.
- Denali Advisors sold 16,409 Usana Health Sciences shares in Q3 2025, an estimated $501K.
- Denali Advisors first reported a position in Usana Health Sciences in Q2 2013 and held it in 27 quarters.
- Denali Advisors's Usana Health Sciences position peaked at $3.19M in Q1 2023.
- 165 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2025.
Based on Denali Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.